ASBP (Aspire-Lakewood Holdings) Beginning Cash Position: $5.86 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASBP Aspire-Lakewood Holdings Inc ASBP
11 GF Score
Price $9.25
! 2 Warning Signs
View Full Analysis

What is Aspire-Lakewood Holdings Beginning Cash Position?

Aspire-Lakewood Holdings ASBP +2.42% 11 Beginning Cash Position is $5.86 Mil as of Jun. 2026. GuruFocus rates ASBP with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

Aspire-Lakewood Holdings's Beginning Cash Position for the quarter that ended in Jun. 2026 was $5.86 Mil.

Aspire-Lakewood Holdings's quarterly Beginning Cash Position declined from Dec. 2025 ($1.95 Mil) to Mar. 2026 ($1.00 Mil) but then increased from Mar. 2026 ($1.00 Mil) to Jun. 2026 ($5.86 Mil).

Aspire-Lakewood Holdings's annual Beginning Cash Position increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.01 Mil) but then declined from Dec. 2024 ($0.01 Mil) to Dec. 2025 ($0.00 Mil).

Aspire-Lakewood Holdings Beginning Cash Position Related Terms

Aspire-Lakewood Holdings Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Aspire-Lakewood Holdings's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspire-Lakewood Holdings Beginning Cash Position Chart

Aspire-Lakewood Holdings Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
0.19 0.00 0.01 0.00

Aspire-Lakewood Holdings Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.35 0.21 1.95 1.00 5.86
ASBP
11GF Score
Aspire-Lakewood Holdings Inc ASBP
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspire-Lakewood Holdings Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $5.86 Mil mean?
Aspire-Lakewood Holdings (ASBP) has a Beginning Cash Position of $5.86 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Aspire-Lakewood Holdings and its competitors.
Is Aspire-Lakewood Holdings' Beginning Cash Position too high?
Aspire-Lakewood Holdings' current Beginning Cash Position is $5.86 Mil. Overall, Aspire-Lakewood Holdings has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Aspire-Lakewood Holdings' Beginning Cash Position compare to PDSB and KPRX?
Aspire-Lakewood Holdings' Beginning Cash Position of $5.86 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Aspire-Lakewood Holdings and its competitors. Aspire-Lakewood Holdings's current Beginning Cash Position is $5.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspire-Lakewood Holdings stock overvalued right now?
Aspire-Lakewood Holdings (ASBP) has a current Beginning Cash Position of $5.86 Mil. The current Beginning Cash Position is $5.86 Mil. Aspire-Lakewood Holdings' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Aspire-Lakewood Holdings (ASBP), the current Beginning Cash Position is $5.86 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aspire-Lakewood Holdings Business Description

Address 23150 Fashion Drive, Suite 232, Estero, FL, USA, 33928
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
11GF Score

Get the complete analysis for ASBP

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.25
Price